Strata Critical Medical (SRTA) Total Non-Current Liabilities (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Total Non-Current Liabilities data on file, last reported at $41.8 million in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $41.8 million, up 50.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.8 million (up 50.62% YoY), and the FY2025 annual result was $44.9 million, up 55.1% from the prior year.
• Total Non-Current Liabilities declined to $41.8 million in Q1 2026 per SRTA's latest filing, from $44.9 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $55.7 million in Q4 2023 and troughed at $16.4 million in Q1 2022.
• A 5-year average of $40.4 million and a median of $44.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 250.67% in 2022, then tumbled 48.04% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $43.5 million in 2022, then gained by 28.14% to $55.7 million in 2023, then plunged by 48.04% to $28.9 million in 2024, then jumped by 55.1% to $44.9 million in 2025, then declined by 6.81% to $41.8 million in 2026.
• Business Quant data shows SRTA's Total Non-Current Liabilities at $41.8 million in Q1 2026, $44.9 million in Q4 2025, and $52.0 million in Q3 2025.